Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects

It is reported that pulmonary fibrosis has become one of the major long-term complications of COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global medical community, there are no treatments for COVID-induced pulmonary fibrosis. Recently, inhalable nanocarrier...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Qianyu, Zhang, Xinrui, Zhou, Dongfang, Xie, Rui, Cai, Yue, Zhang, Kehao, Sun, Xuanrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329312/
https://www.ncbi.nlm.nih.gov/pubmed/37422665
http://dx.doi.org/10.1186/s12951-023-01971-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329312/
https://www.ncbi.nlm.nih.gov/pubmed/37422665
http://dx.doi.org/10.1186/s12951-023-01971-7

Ejemplares similares